18983288589(微信同号)
18983288589(微信同号)
18908392210(微信同号)
18980413049
ChiCTR2100050850
正在进行
/
/
/
2021-09-05
/
/
Stroke
Chau Pak Chun Janita:请与我们联系上传伦理审查文件 Effects of a social participation-focused virtual reality intervention on the physical, psychological and social outcomes of community-dwelli
Effects of a social participation-focused virtual reality intervention on the physical, psychological and social outcomes of community-dwelling stroke survivors with physical disabilities
To develop and evaluate the effectiveness of a social participation-focused virtual reality (SP-VR) intervention on the physical, psychological, and social outcomes of community-dwelling stroke survivors with physical disabilities.
随机平行对照
其它
Participants will be allocated to the study arms using permuted block randomisation with varying block sizes in a 1:1 ratio. This will maintain a good balance of participants and optimise allocation concealment throughout the recruitment period.
Not stated
General Research Fund, Research Grant Council
/
276
/
2021-10-01
2023-12-31
/
Participants will be recruited from the stroke units of three acute and one rehabilitation hospitals and three stroke nurss-led clinics in a single region. We will recruit 276 stroke survivor–caregiver dyads. The following inclusion criteria will be applied to the stroke survivors: 1. Aged >=18 years; 2. A diagnosis of ischaemic or haemorrhagic stroke resulting in physical disability; 3. Study entry within 6 months post-stroke; 4. The ability to remain in a sitting position with support; 5. A Montreal Cognitive Assessment score (HK-MOCA version) above the second percentile; 6. The absence of limb deformities and other neurological or musculoskeletal disorders; 7. Residence in the community. The study will include survivors of a first stroke and those with a history of stroke. Caregivers who provide most care to the survivor will also be included. Both members of the dyad must be able to communicate in Chinese.;
登录查看Both members of the dyad will be excluded if they have 1. A psychiatric condition (e.g. symptoms of delusion or hallucinations); 2. A history of vestibular deficits or severe visual impairments; 3. Any seizure activity during the previous 6 months; 4. Difficulty in following instructions.;
登录查看N/A
/
精准药物2024-11-23
亚泰制药2024-11-23
昌郁医药2024-11-22
上海和誉生物医药科技有限公司2024-11-22
云顶新耀2024-11-22
金斯瑞生物2024-11-22
细胞与基因治疗领域2024-11-22
肝脏时间2024-11-22
医药笔记2024-11-22
生物安全情报网2024-11-22